Company Filing History:
Years Active: 2023
Title: Jamie M McCabe Dunn: Innovator in Sugammadex Preparation
Introduction
Jamie M McCabe Dunn is a notable inventor based in Cranford, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of sugammadex. His innovative processes have the potential to enhance the efficiency of drug production.
Latest Patents
Jamie M McCabe Dunn holds 1 patent related to the preparation of sugammadex. The patent outlines various processes, including the preparation of sugammadex from 8-per-deoxy-8-bromo-γ-cyclodextrin and 3-mercaptopropionic acid. Additionally, it describes alternative methods for synthesizing sugammadex using disodium 3-mercaptopropionate. The patent also details the preparation of 8-per-deoxy-8-bromo-γ-cyclodextrin, which is crucial for the production of sugammadex.
Career Highlights
Jamie is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His work focuses on developing innovative pharmaceutical processes that can improve drug formulations and delivery.
Collaborations
Throughout his career, Jamie has collaborated with talented professionals, including Nadine Kuhl and Wenyong Chen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jamie M McCabe Dunn is a distinguished inventor whose work in the preparation of sugammadex showcases his commitment to advancing pharmaceutical science. His contributions are valuable to the industry and highlight the importance of innovation in drug development.